|
Sociodemographic characteristics
| | | | |
|
Age
|
.002
|
.011
|
.009
| |
|
Living with a partner
|
−.511
|
.216
|
−.117
| |
|
Higher education
|
−.05
|
.115
|
−.021
| |
|
Still working vs. retired
|
.137
|
.204
|
.042
|
.033
|
|
Group: RP vs. AS
|
.016
|
.143
|
.007
|
.06
|
|
Tumor risk category
| | | | |
|
Gleason-Score (4–6)
|
.305
|
.141
|
.116
| |
|
PSA
|
.004
|
.019
|
.012
|
.002
|
|
Time since treatment decision (months)
|
.004
|
.004
|
.056
|
.004
|
|
Number of comorbidities
|
.039
|
.039
|
.051
|
.01
|
|
Importance of sexuality
|
.252
|
.074
|
.184
|
.048**
|
|
Changes in erectile functioning
|
.668
|
.069
|
.567
|
.207***
|
|
Importance of sexuality*changes in erectile functioning
|
.318
|
.062
|
.257
|
.062***
|
| | | |
R2 = .426 Adjusted R2 = .398 F = 14.93***
|